Improved experimental time of ultra-large bioassays using a parallelised microfluidic biochip architecture/scheduling.

Digital microfluidic is an emerging technology to reduce the cost and time of experiments and improve the flexibility, automate-ability and correctness of biochemical assays. In many of applications such as drug discovery and DNA profiling, a large number of bio-operations (e.g.